About
Onco Response is a clinical-stage biotechnology company focused on developing personalized cell therapies for solid tumors, leveraging T cell receptor (TCR) engineering to target cancer antigens.
Explore Onco Response's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.